scholarly journals Changes in Content of Articles Relating to Medical Pharmacy in Japan-"Japanese Journal of Pharmaceutical Health Care and Sciences/Japanese Journal of Hospital Pharmacy" and "YAKUZAIGAKU/Journal of Pharmaceutical Science and Technology Japan"-

2009 ◽  
Vol 35 (1) ◽  
pp. 37-42 ◽  
Author(s):  
Masanori Iwata ◽  
Mami Takigawa ◽  
Takuro Shimozono ◽  
Yukiko Nomoto ◽  
Mayumi Kaneda ◽  
...  
Keyword(s):  
Health Care ◽  
Hospital Pharmacy ◽  
Science And Technology ◽  
Japanese Journal ◽  
Pharmaceutical Science

scholarly journals Good Hospital Pharmacy Practices for Better Health Care of People

1970 ◽  
Vol 1 (1) ◽  
pp. 1-2
Author(s):  
Feroz Uddin Ahmed
Keyword(s):  
Health Care ◽  
Hospital Pharmacy

doi:10:3329/sjps.v1i1.1778S. J. Pharm. Sci. 1(1&2): 1-2

scholarly journals Cognitive Computing and Watson: Implications for Hospital Pharmacy

2018 ◽  
Vol 54 (1) ◽  
pp. 20-21
Author(s):  
Brent I. Fox
Keyword(s):  
Health Care ◽  
Health Care System ◽  
Hospital Pharmacy ◽  
Cognitive Computing ◽  
Care System

This installment explores the domain of cognitive computing, using the well-known Watson as an example. The migration of computer manufacturers from a focus on hardware to a focus on services suggests the potential of these tools. Considerations for use of these tools in the health care system are provided.

Ondansetron: Cholestatic Pruritus (Adults)

2009 ◽  
Vol 44 (10) ◽  
pp. 868-869
Author(s):  
Joyce A. Generali ◽  
Dennis J. Cada
Keyword(s):  
Health Care ◽  
Patient Care ◽  
Health Care Professional ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Specific Drug ◽  
Off Label ◽  
Comprehensive Information ◽  
The Us ◽  
Therapeutic Considerations

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. A summary of the most relevant data is provided, including background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to hospital [email protected] .

Maximizing your Organizer Skills

2002 ◽  
Vol 37 (8) ◽  
pp. 871-876
Author(s):  
Brent I. Fox ◽  
Bill G. Felkey
Keyword(s):  
Health Care ◽  
Hospital Pharmacy ◽  
Care Setting ◽  
Health Care Setting ◽  
Auburn University ◽  
Care Systems ◽  
Mailing Address ◽  
E Mail

An upcoming issue will feature readers' experiences with PDAs in the health care setting. Please e-mail any stories you would like to share with other Hospital Pharmacy readers to either of the authors at [email protected] or [email protected] . You may also send your contributions, questions, or comments to the authors (who share the same mailing address) at The Auburn University Harrison School of Pharmacy, Pharmacy Care Systems,128 Miller Hall, Auburn, AL 36849.

Atorvastatin: Rheumatoid Arthritis

2005 ◽  
Vol 40 (2) ◽  
pp. 144-183
Author(s):  
Joyce Generali ◽  
Dennis J. Cada
Keyword(s):  
Rheumatoid Arthritis ◽  
Health Care ◽  
Patient Care ◽  
Health Care Professional ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Tabular Form ◽  
Off Label ◽  
Comprehensive Information ◽  
Therapeutic Considerations

Off-Label Drug Uses This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Facts and Comparisons. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses. This new guide to the literature will enable the health care professional/clinician to quickly identify published studies on off-label uses and to determine if a specific use is rational in a patient care scenario. The most relevant data are provided in tabular form so that the reader can easily identify the scope of information available. A summary of the data—including background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations—precedes each table of published studies. References direct the reader to the full literature for more comprehensive information prior to patient care decisions. Direct questions or comments on “Off-Label Drug Uses” to [email protected] .

Gabapentin: Hyperhidrosis

2003 ◽  
Vol 38 (1) ◽  
pp. 25-26
Author(s):  
Joyce Generali ◽  
Dennis J. Cada
Keyword(s):  
Health Care ◽  
Patient Care ◽  
Health Care Professional ◽  
Study Design ◽  
Patient Population ◽  
Hospital Pharmacy ◽  
Tabular Form ◽  
Off Label ◽  
Comprehensive Information ◽  
Therapeutic Considerations

Off-Label Drug Uses This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Facts and Comparisons. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses. This new guide to the literature will enable the health care professional/clinician to quickly identify published studies on off-label uses and to determine if a specific use is rational in a patient care scenario. The most relevant data are provided in tabular form so that the reader can easily identify the scope of information available. A summary of the data—including, background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations—precedes each table of published studies. References direct the reader to the full literature for more comprehensive information prior to patient care decisions. Direct questions or comments on “Off-Label Drug Uses” to [email protected] .

Topiramate: Weight Loss (Antipsychotic-Agent-Induced Weight Gain or Obesity)

2003 ◽  
Vol 38 (4) ◽  
pp. 328-336
Author(s):  
Joyce Generali ◽  
Dennis J. Cada
Keyword(s):  
Health Care ◽  
Weight Loss ◽  
Weight Gain ◽  
Patient Care ◽  
Hospital Pharmacy ◽  
Antipsychotic Agent ◽  
Tabular Form ◽  
Off Label ◽  
Comprehensive Information ◽  
Therapeutic Considerations

Off-Label Drug Uses-This Hospital Pharmacy feature is extracted from Off-Label DrugFacts, a quarterly publication available from Facts and Comparisons. Off-Label DrugFacts is a practitioner-oriented resource for information about specific FDA-unapproved drug uses. This new guide to the literature will enable the health care professional/clinician to quickly identify published studies on off-label uses and to determine if a specific use is rational in a patient care scenario. The most relevant data are provided in tabular form so that the reader can easily identify the scope of information available. A summary of the data—including, background, study design, patient population, dosage information, therapy duration, results, safety, and therapeutic considerations—precedes each table of published studies. References direct the reader to the full literature for more comprehensive information prior to patient care decisions. Direct questions or comments on “Off-Label Drug Uses” to [email protected] .

Sign in / Sign up

Export Citation Format

Share Document